| Value | ₹15.57 Cr |
|---|
NSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹29.18
- Market cap
- ₹46.19 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 41.3×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics appointed Prabhakar Raghunath Zavar as Non-Executive Independent Director for 60 months, effective 15 September 2026. The disclosure covers a board-level appointment with a background profile and no monetary amount.
- Execution
- 60 months
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹1,557 Cr
Mangalam Drugs and Organics Limited has reported a default amounting to Rs.1,557.27 Crore. The company has submitted a restructuring proposal to its banks to manage the obligation.
- Value
- ₹1,557 Cr
Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr
Mangalam Drugs and Organics Limited reported defaults on bank loan obligations totaling Rs. 15.57 Crore. The defaults involve cash credit accounts at Bank of Maharashtra and Bank of Baroda.
- Value
- ₹15.57 Cr
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Limited has issued a Postal Ballot notice to seek shareholder approval for appointing Shri Prabhakar Raghunath Zavar as an Independent Director. The appointment is for five years.
Other legal & regulatory announcements
All →Corona Remedies Legal & Regulatory
Corona Remedies received an NPPA demand notice of Rs 4.88 Crore for alleged DPCO 2013 price violations. The company is evaluating it and reports no material financial impact.
- Value
- ₹4.88 Cr
Easy Trip Planners Legal & Regulatory
Easy Trip Planners received a GST show-cause notice proposing a penalty of about Rs 67.41 Crore. The company expects no immediate financial impact and will contest it.
- Value
- ₹67.41 Cr
Ruparel Food Products Legal & Regulatory
Ruparel Food Products paid a Rs 2,360 BSE fine for a late Regulation 34 annual report. The company says Regulation 43A does not apply to it.
- Value
- ₹0.00 Cr
Integra Switchgear Legal & Regulatory
Integra Switchgear received a SEBI adjudication order levying penalties of ₹13 lakh. The erstwhile promoters have undertaken to bear any resulting liability.
- Value
- ₹0.13 Cr
- From
- Securities and Exchange Board of India (SEBI)
Airfloa Rail Technology Legal & Regulatory
Airfloa Rail received a Madras High Court interim stay on CSR penalties under Section 135(7). Conditional relief requires paying 50% of the ROC penalty within twelve weeks.
- Value
- ₹1.05 Cr
Timken India Legal & Regulatory
Timken India's GST appeal was rejected, upholding a Rs 8.19 Crore demand plus interest and penalty. The company plans to appeal and expects no immediate financial impact.
- Value
- ₹8.19 Cr